½Å°æ ±â±â ½ÃÀå : ±âȸ, ¼ºÀå ÃËÁø¿äÀÎ, »ê¾÷ µ¿Ç⠺м®, ¿¹Ãø(2025-2034³â)
Neurology Devices Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034
»óǰÄÚµå : 1755203
¸®¼­Ä¡»ç : Global Market Insights Inc.
¹ßÇàÀÏ : 2025³â 05¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 165 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,850 £Ü 6,630,000
PDF & Excel (Single User License) help
PDF, Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,050 £Ü 8,270,000
PDF & Excel (Multi User License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,350 £Ü 11,415,000
PDF & Excel (Enterprise User License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°è ½Å°æ ±â±â ½ÃÀåÀº 2024³â 143¾ï ´Þ·¯·Î Æò°¡µÇ¾úÀ¸¸ç, ±â¼ú Çõ½Å, ½Å°æÁúȯ ¹ß»ý·ü »ó½Â, ÇコÄɾî ÁöÃâ Áõ°¡, ÀÇ·á¼­ºñ½º Á¢±Ù¼º °³¼± µîÀÌ °áÇյǾî CAGR 7.2%·Î ¼ºÀåÇØ 2034³â 283¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ÃßÁ¤µÇ°í ÀÖ½À´Ï´Ù.

AI¸¦ Ȱ¿ëÇÑ ¿ø°Ý ¸ð´ÏÅ͸µ°ú ºê·¹ÀÎ ÄÄÇ»ÅÍ ÀÎÅÍÆäÀ̽º ½Ã½ºÅÛÀÇ °³¹ß·Î ȯÀÚÀÇ Ä¡·á ¼ºÀûÀÌ ´ëÆø Çâ»óµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Áøº¸´Â º¸´Ù Á¤È®ÇÏ°í ¾ÈÀüÇϸç È¿À²ÀûÀÎ Ä¡·á °³ÀÔÀ» °¡´ÉÇÏ°Ô Çϸç, ½Å°æ ±â±â ºÐ¾ß ÀüüÀÇ È®´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

½Å°æ ±â±â Market-IMG1

½Å°æ ±â±â´Â ³ú, ôÃß, ¸»ÃÊ ½Å°æ°ú °°Àº ½Å°æ°è¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â »óŸ¦ °ü¸®ÇÏ´Â µ¥ »ç¿ëµÇ´Â ÀÌ½Ä °¡´ÉÇÑ µµ±¸, ¼ö¼ú µµ±¸, Áø´Ü ±â¼úÀ» Æ÷ÇÔÇÕ´Ï´Ù. ÀÌ ÀåÄ¡µéÀº ³úÀüÁõ, ÆÄŲ½¼º´, ¾ËÃ÷ÇÏÀ̸Ӻ´, ´Ù¹ß¼º °æÈ­Áõ, ³úÁ¾¾ç ¹× ¿Ü»ó¼º ³ú ¼Õ»óÀ» Æ÷ÇÔÇÑ ½Å°æ ÁúȯÀÇ ¹ß°ß, ¸ð´ÏÅ͸µ, Ä¡·á ¹× ÀçȰÀ» µ½±â À§ÇØ ¼³°èµÇ¾ú½À´Ï´Ù. ÀÏ»óÀûÀÎ ½Å°æÇÐÀû Æò°¡¿¡¼­ º¹ÀâÇÑ ½Å°æ¿Ü°úÀû Ä¡·á¿¡ À̸£±â±îÁö ´Ù¾çÇÑ ÀÓ»ó Àå¸é¿¡¼­ Áß¿äÇÑ ¿ªÇÒÀ» ´ã´çÇϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¹üÀ§
½ÃÀÛ ¿¬µµ 2024³â
¿¹Ãø ¿¬µµ 2025-2034³â
½ÃÀÛ ±Ý¾× 143¾ï ´Þ·¯
¿¹Ãø ±Ý¾× 283¾ï ´Þ·¯
CAGR 7.2%

ÁÖ¿ä Ä«Å×°í¸® Áß ½Å°æ ÀÚ±Ø ÀåÄ¡ ºÎ¹®Àº 2024³â¿¡ 70¾ï ´Þ·¯¸¦ »ý»êÇß½À´Ï´Ù. Æó¼âÇü ·çÇÁ ½Ã½ºÅÛ, MRI ´ëÀÀ ÀÓÇöõÆ®, ¼ÒÇüÈ­ ¼Ö·ç¼Ç µîÀÇ »õ·Î¿î ¸ðµ¨Àº ȯÀÚÀÇ °á°ú¸¦ °³¼±Çϰí Ä¡·á ¿ëµµ¸¦ ³ÐÇô ÀÌ ºÎ¹®ÀÇ ¼ºÀåÀ» °­È­Çϰí ÀÖ½À´Ï´Ù.

ÃÖÁ¾ ¿ëµµº°·Î º´¿øÀº Á¾ÇÕÀûÀÎ ÀÎÇÁ¶ó¿Í º¹ÀâÇÑ ½Å°æÇÐÀû »ç·Ê¿¡ ´ëÇÑ ´ëÀÀ ´É·ÂÀ» ¹è°æÀ¸·Î 2024³â ½ÃÀåÀ» 56.1%ÀÇ ¾ÐµµÀûÀÎ Á¡À¯À²·Î °ßÀÎÇß½À´Ï´Ù. º´¿øÀº Áø´ÜÀ̳ª Ä¡·á óġÀÇ ´ëºÎºÐÀ» ½Ç½ÃÇϱ⠶§¹®¿¡ ½Å°æ È­»ó Áø´Ü ½Ã½ºÅÛÀ̳ª ½Å°æ Á¶Àý ½Ã½ºÅÛÀÇ µµÀÔ¿¡ À־ Áß¿äÇÑ °ÅÁ¡ÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¹ßÀÛ, ³úÁ¹Áß, ¿Ü»ó µî ½Å°æÇÐÀû ±ä±Þ »çŸ¦ °ü¸®ÇÏ´Â ¿ªÇÒÀ» ´ã´çÇϰí Àֱ⠶§¹®¿¡ ÃÖ÷´Ü Àåºñ¿¡ ´ëÇÑ ¼ö¿ä´Â ²÷ÀÓ¾øÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù.

¹Ì±¹ÀÇ ½Å°æ ±â±â 2024³â ½ÃÀå ±Ô¸ð´Â 52¾ï ´Þ·¯·Î, ½Å°æÁúȯ À¯º´·ü Áõ°¡, °ß°íÇÑ Àӻ󿬱¸ ÀÎÇÁ¶ó, Á¤ºÎÀÇ ¾öû³­ ÀÚ±Ý Áö¿øÀ» Áö¿øÇϰí ÀÖ½À´Ï´Ù. ÁÖ¿ä ¿¬¹æ Á¤ºÎÀÇ ÀÌ´Ï¼ÅÆ¼ºê¿Í ¿¬±¸ º¸Á¶±ÝÀº ½Å°æ º¸Ã¶°ú ºê·¹ÀÎ ÄÄÇ»ÅÍ ÀÎÅÍÆäÀ̽º ½Ã½ºÅÛÀÇ Áøº¸¸¦ °è¼Ó Áö¿øÇÕ´Ï´Ù. ³ëÀÎ Àα¸ Áõ°¡¿Í ½Å°æÇÐÀÇ Àü¹®°¡ ºÎÁ·µµ, Áõ°¡ÇÏ´Â ÄÉ¾î ¼ö¿ä¿¡ ´ëÀÀÇϱâ À§ÇØ, ¼±Áø ±â±â¿¡ÀÇ ÀÇÁ¸µµ¸¦ ³ôÀ̰í ÀÖ½À´Ï´Ù.

½Å°æ ±â±â ¾÷°è Á¤¼¼¸¦ Àû±ØÀûÀ¸·Î Çü¼ºÇÏ´Â ÁÖ¿ä ±â¾÷Àº Synchron, B BRAUN, LivaNova, NeuroPace, ZYLOX TONBRIDGE, Abbott Laboratories, MicroTransponder, KARL STROZ, Medtronic, stryker, Bioness, nevro, Boston Scientific, Enterra Medical, Paradromics µî ÁÖ¿ä ±â¾÷Àº ½Å°æ ±â±â ½ÃÀå¿¡¼­ÀÇ ÁöÀ§¸¦ °­È­Çϱâ À§ÇØ ¿¬±¸ ÁÖµµÇü Á¦Ç° Çõ½Å°ú AI ÅëÇÕ ½Ã½ºÅÛ ½ÃÀå °³Ã´¿¡ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¾÷ÀÇ Á¢±Ù ¹æ½ÄÀÇ Áß½ÉÀÌ µÇ°í ÀÖ½À´Ï´Ù. °¢ ±â¾÷Àº À̹Ì¡ ½Ã½ºÅÛ°úÀÇ Àåºñ ȣȯ¼ºÀ» °³¼±ÇÏ°í º¸´Ù ±¤¹üÀ§ÇÑ ÀÓ»ó »ç¿ëÀ» À§ÇØ ÄÄÆÑÆ®Çϰí ÈÞ´ë °¡´ÉÇÑ Çü½ÄÀ» Ãß±¸Çϰí ÀÖ½À´Ï´Ù. ´ë±â¾÷Àº Á¦Á¶ ´É·ÂÀ» È®´ëÇϰí, °è¾àÀ» È®º¸Çϰí, Áö¸®Àû Á¸À縦 ³ôÀ̰í, º¸´Ù ½º¸¶Æ®ÇÑ ½Å°æÇÐÀû ÄɾîÀÇ Á¦°øÀ» ¸ñÇ¥·Î ÇÏ´Â Çコ ÄÉ¾î ½Ã½ºÅÛ°ú ¿¬°èÇϱâ À§ÇØ, ¼¼°èÀûÀÎ Çù·Â °ü°è¸¦ ¸Î°íÀÚ Çϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ¾÷°è ÀλçÀÌÆ®

Á¦4Àå °æÀï ±¸µµ

Á¦5Àå ½ÃÀå ÃßÁ¤ ¹× ¿¹Ãø : µð¹ÙÀ̽ºº°, 2021³â-2034³â

Á¦6Àå ½ÃÀå ÃßÁ¤ ¹× ¿¹Ãø : ¿ëµµº°, 2021³â-2034³â

Á¦7Àå ½ÃÀå ÃßÁ¤ ¹× ¿¹Ãø : ÃÖÁ¾ ¿ëµµº°, 2021³â-2034³â

Á¦8Àå ½ÃÀå ÃßÁ¤ ¹× ¿¹Ãø : Áö¿ªº°, 2021³â-2034³â

Á¦9Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ

SHW
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The Global Neurology Devices Market was valued at USD 14.3 billion in 2024 and is estimated to grow at a CAGR of 7.2% to reach USD 28.3 billion by 2034, fueled by a combination of technological innovation, rising rates of neurological conditions, increased healthcare spending, and improved access to medical services. Developments in AI-powered remote monitoring and brain-computer interface systems have significantly improved patient care outcomes. In addition, emerging minimally invasive neurotechnologies-such as portable EEG monitors and enhanced stimulation systems-are transforming neurological treatment and diagnosis. These advances have made it possible to deliver more precise, safer, and efficient therapeutic interventions, contributing to the overall expansion of the neurology devices sector. Neurology devices include implantable tools, surgical instruments, and diagnostic technologies used to manage conditions affecting the nervous system, such as the brain, spine, and peripheral nerves.

Neurology Devices Market - IMG1

Neurology devices include implantable tools, surgical instruments, and diagnostic technologies used to manage conditions affecting the nervous system, such as the brain, spine, and peripheral nerves. These devices are designed to aid in the detection, monitoring, treatment, and rehabilitation of neurological disorders, including epilepsy, Parkinson's disease, Alzheimer's disease, multiple sclerosis, brain tumors, and traumatic brain injuries. They serve a critical role across a range of clinical settings, from routine neurological assessments to complex neurosurgical procedures. Diagnostic tools such as EEG systems and neuroimaging technologies help in the early and accurate identification of neurological conditions, while implantable devices like neurostimulators offer long-term therapeutic benefits for patients suffering from chronic and progressive diseases.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$14.3 Billion
Forecast Value$28.3 Billion
CAGR7.2%

Among the main categories, the neurostimulation devices segment generated USD 7 billion in 2024. These include systems like spinal cord stimulators and vagus nerve stimulators, designed to address movement disorders, chronic pain, psychiatric issues, and epilepsy. Newer models, such as closed-loop systems, MRI-compatible implants, and miniaturized solutions, have improved patient outcomes and broadened therapeutic applications, reinforcing growth in this segment.

By end use, hospitals led the market in 2024 with a dominant share of 56.1%, driven by their comprehensive infrastructure and ability to handle complex neurological cases. Hospitals conduct a majority of diagnostic and therapeutic procedures, making them key hubs for the adoption of neuroimaging and neuromodulation systems. Their role in managing emergency neurological events such as seizures, strokes, and traumatic injuries ensures constant demand for cutting-edge equipment.

United States Neurology Devices Market was valued at USD 5.2 billion in 2024, supported by increasing neurological disease prevalence, robust clinical research infrastructure, and substantial government funding. Major federal initiatives and research grants continue to back advancements in neuroprosthetics and brain-computer interface systems. A growing elderly population and a shortage of specialized neurology professionals are also pushing greater reliance on advanced devices to meet the rising demand for care.

Key players actively shaping The Neurology Devices Industry landscape include Synchron, B BRAUN, LivaNova, NeuroPace, ZYLOX TONBRIDGE, Abbott Laboratories, MicroTransponder, KARL STROZ, Medtronic, stryker, Bioness, nevro, Boston Scientific, Enterra Medical, and Paradromics. To strengthen their position in the neurology devices market, leading companies are focusing on research-driven product innovation and the development of AI-integrated systems. These firms are expanding their portfolios with minimally invasive devices and patient-specific solutions that enhance safety and precision. Strategic partnerships, regulatory approvals, and increased investments in neurotechnology R&D are also central to their approach. Businesses are refining device compatibility with imaging systems and pursuing compact, portable formats for broader clinical use. Additionally, major players are scaling up manufacturing capabilities and entering into global collaborations to secure contracts, boost geographic presence, and align with healthcare systems aiming for smarter neurological care delivery.

Table of Contents

Chapter 1 Methodology and Scope

Chapter 2 Executive Summary

Chapter 3 Industry Insights

Chapter 4 Competitive Landscape, 2024

Chapter 5 Market Estimates and Forecast, By Device, 2021 - 2034 ($ Mn)

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2034 ($ Mn)

Chapter 7 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

Chapter 9 Company Profiles

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â